Psychiatric Disorders in Dermatiological Diseases
ConditionBody Dysmorhpic Disorder
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorSohag University
About this trial
The aim of this study:
1. Evaluate the presence of body dysmorphic disorder in children with dermatological diseases compared to healthy controls. 2. Assess the effect of these skin diseases on the quality of life in those children.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
The study will include 250 children of both sexes aged from six up to less than 18 years presenting with various chronic skin diseases, diagnosed clinically, by dermoscopy and by biopsy if needed, and age and sex matched healthy controls.
Ability of the child and caregiver to understand and respond to the questionnaires.
Disqualifiers
Children with diagnosed psychiatric disorders other than BDD (e.g., severe depression, autism spectrum disorder).
Children with chronic systemic illness affecting body image or any other debilitating acute , chronic illness or surgical problems e.g.: short stature, hypothyroidism, osteochondral defects and obesity.
Trial population
The study will include 250 patients with dermatological diseases and 250 age and sex matched healthy controls. From Dermatology outpatient clinics, Sohag University Hospitals, Faculty of Medicine Sohag University.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Questionnaire and Physical Exam
Other interventionThe Body Dysmorphic Disorder Questionnaire (BDDQ) : The BDD-Q is a brief, validated self-administered questionnaire that is used to identify patients having symptoms of BDD. It uses close-ended questions and identifies if participants' concerns regarding appearance are a source of preoccupation. It also identifies the grade of distress or interference with social and occupational functioning caused by these concerns . It has good validity, high sensitivity (100%) and specificity (89- 93%) for screening for BDD . BDD diagnosis is likely if answers to question (1) (preoccupation) are yes to both parts, answers to question 3 (significant stress) include yes to any of the questions and answers to question (4) (time spent thinking about defect) include b or c choices.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Evaluation of Body Dysmorphic Disorder in Children with Dermatological Diseases
Evaluate the presence of body dysmorphic disorder in children with dermatological diseases compared to healthy controls. The study will include 250 children of both sexes aged from six to less than 18 years presented with various chronic skin diseases, diagnosed clinically , by dermoscopy and by biopsy if needed, and 250 age and sex matched healthy controls . Assessment of the severity of the dermatological diseases according to available valid severity scores will be done . Body Dysmorphic Disorder Questionnaire Dermatology Version will be done to identify symptoms of body dysmorphic disorder with valid standardized arabic version . The body dysmorphic disorder questionnaire is a brief, validated questionnaire used to identify patients having symptoms of BDD. It uses close-ended questions and identifies if participants' concerns regarding appearance are a source of preoccupation and identifies the grade of distress or interference with social and occupational functioning .
Time frame
From Apri 2026 to April 20272
Assess the effect of skin diseases on the quality of life of children
Assess the effect of skin diseases on the quality of life in children by using Children's Dermatology Life Quality Index questionnaire (CDLQI) that used to evaluate the psychosocial impact of skin disease with valid standardized Arabic version . The study will include 250 children of both sexes aged from six up to less than 18 years presenting with various chronic skin diseases, diagnosed clinically, by dermoscopy and by biopsy if needed, and 250 age and sex matched healthy controls then Children's Dermatology Life Quality Index questionnaire (CDLQI) will be assessed with a valid standardized Arabic version . The Children's Dermatology Life Quality Index (CDLQI) is a validated questionnaire to assess the impact of skin diseases on the quality of life of children. It evaluates the effect of dermatological conditions on physical symptoms, emotional well-being, daily activities, social interactions, school performance, and treatment.
Time frame
From April 2026 to April 2027Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: